Services

Therapeutic Program Offerings

We provide a solution for those seeking psychedelic-assisted therapy in a safe, legal environment. 

Our research-based approach to psychedelic-assisted therapeutics creates a personalized experience designed to optimize patient outcomes and inspire lasting change for a variety of mental health disorders; such as PTSD, depression, grief, anxiety and more. 

At InnerPath, expert practitioners employ our proprietary protocols to work in concert with established psychotherapy models, such as Cognitive Behavioural Therapy, Mindfulness-based Cognitive Therapy, Internal Family Systems, and Psychedelic Integration and Harm Reduction in a regulated, non-clinical setting to optimize patient outcomes–and setting the standard for psychedelic-assisted psychotherapy.

Drug Development Support

Our modern world needs new treatments and medicines to meet the growing number of mental health disorders worldwide. We see the renaissance of psychedelic treatment therapies as critical for the next evolution in healthcare and we provide the necessary clinical trial support for companies currently leading this research.

We provide the necessary framework for research and innovation in the field of psychiatric, psychopharmacological and psychedelic application and study. We offer an unprecedented multi-psychedelic research opportunity in a legal and regulated environment. 

We support psychedelic drug development by providing: 

• Pre-clinical human use data

• Phase I and Phase II trial support